Pernot, S., Dubreuil, O., Aparicio, T., Le Malicot, K., Tougeron, D., Lepère, C., . . . Taieb, J. (2018). Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: An AGEO multicentre study. Br J Cancer.
Stile di citazione ChicagoPernot, Simon, et al. "Efficacy of a Docetaxel-5FU-oxaliplatin Regimen (TEFOX) in First-line Treatment of Advanced Gastric Signet Ring Cell Carcinoma: An AGEO Multicentre Study." Br J Cancer 2018.
Citazione MLAPernot, Simon, et al. "Efficacy of a Docetaxel-5FU-oxaliplatin Regimen (TEFOX) in First-line Treatment of Advanced Gastric Signet Ring Cell Carcinoma: An AGEO Multicentre Study." Br J Cancer 2018.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.